Unaudited standalone and consolidated Financial Results for the quarter and half year ended on 30 September, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Ltd has submitted to BSE copies of newspaper advertisements containing its unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2025, as required under SEBI Regulation 47. The advertisements were published on 12 November 2025 in Financial Express (English) and Naya India (Hindi). The financial results themselves were approved earlier, on 11 November 2025. No specific financial numbers or profit/loss figures are included in this filing. The advertisement and intimation have also been made available on the company's website.
This is a routine regulatory compliance filing and does not contain any new financial data or business update. Shareholders do not need to take any action; investors should refer to the actual approved results filed earlier on 11 November 2025 for financial details.